MedComms Experts and NexGen Unite to Revolutionize Healthcare Communications Strategies

MedComms Experts Merges with NexGen Healthcare Communications

In a significant move within the healthcare communications landscape, MedComms Experts (MCE), a globally recognized medical communications agency backed by The Brydon Group, has officially acquired NexGen Healthcare Communications, a UK-based agency known for its integrated approach to medical and commercial communications in the life sciences sector. This strategic acquisition not only combines two well-respected organizations but also aligns them under a shared mission of enhancing communication strategies tailored for the needs of life sciences companies.

A New Era of Strategic Communication

John Ribble, the CEO of MCE, expressed his excitement about the acquisition, stating, "Together, we offer a powerful blend of strategic insight and scientific excellence, enhanced by a broader range of capabilities." The union allows MedComms Experts to leverage NexGen’s expertise, enabling an unparalleled service offering across Medical Affairs, Commercial, and Patient Advocacy functions.

Wesley Portegies, Chief Strategy Officer and Founder of MCE, highlighted the strategic reasoning behind this merger. He believes that joining forces with NexGen will unlock new opportunities for outreach and expertise within Commercial and Patient Engagement functions. Portegies also emphasized the cultural compatibility between the two firms, which focuses on a unified commitment to science and effective communication strategies.

Client-Centric Improvements

The acquisition promises several key benefits for clients, notably the promotion of unified communications across various stakeholder groups. This will lead to a cohesive and cross-functional approach to messaging, ensuring scientific integrity and emotional resonance. Furthermore, clients will have access to end-to-end publication services characterized by strategic depth, from planning and development to optimizing the impact of publication outputs.

One standout advantage is the enhanced engagement with healthcare professionals (HCPs) through advanced, digital-first platforms. Both MCE and NexGen possess proven strengths in digital engagement and data-driven content strategies, ensuring that vital communications are timely, accessible, and tailored specifically to HCP needs.

In addition, the merger will enhance patient engagement strategies. With combined expertise in disease state content and advocacy materials, clients will have access to tools that educate and empower patients throughout their treatment journeys.

About MedComms Experts and NexGen

MedComms Experts has built a reputation specializing in rare diseases and is committed to bridging the gap between complex scientific communications and clarity. With offices in New York and Zurich, MCE works closely with biopharma companies to facilitate effective engagement with healthcare professionals.

NexGen Healthcare Communications, on the other hand, prides itself on being a full-service medical communication agency with a presence in both the UK and US. They focus on creating strategic communications and medical education while leveraging innovative content to make a measurable impact on their clients.

The Brydon Group, known for supporting growth-oriented investment strategies in healthcare and technology sectors, has backed this merger, underscoring the promise of a robust platform equipped for ongoing growth and innovation in medical communications. Kyle Herman, Principal at The Brydon Group, stated, "This combination strengthens the platform's capabilities and positions the business for continued growth and innovation in the years ahead."

Overall, the acquisition of NexGen by MedComms Experts marks a pivotal moment for both organizations, promising to reshape the way life sciences companies communicate with their audiences. As businesses navigate an increasingly complex healthcare landscape, this partnership aims to enhance strategic scientific communication, ultimately driving better outcomes for patients and stakeholders alike.